At the time of writing, Coeptis Therapeutics Holdings Inc [COEP] stock is trading at $0.24, up 17.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The COEP shares have gain 20.67% over the last week, with a monthly amount glided 20.36%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
For the past year, the stock price of Coeptis Therapeutics Holdings Inc fluctuated between $0.15 and $1.28. Coeptis Therapeutics Holdings Inc [NASDAQ: COEP] shares were valued at $0.24 at the most recent close of the market.
Analyzing the COEP fundamentals
Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at -7.5%, Pretax Profit Margin comes in at -7.74%, and Net Profit Margin reading is -7.74%. To continue investigating profitability, this company’s Return on Assets is posted at -1.3, Equity is -2.26 and Total Capital is -2.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2069 points at the first support level, and at 0.1754 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2571, and for the 2nd resistance point, it is at 0.2758.
Ratios To Look Out For
It is important to note that Coeptis Therapeutics Holdings Inc [NASDAQ:COEP] has a current ratio of 0.40. On the other hand, the Quick Ratio is 0.40, and the Cash Ratio is 0.33.
Transactions by insiders
Recent insider trading involved Cogley Brian, Chief Financial Officer, that happened on Jan 10 ’24 when 5000.0 shares were purchased. Director, DeSilva Tara completed a deal on Jan 12 ’24 to buy 2266.0 shares. Meanwhile, VP of Operations Yerace Daniel Alexander bought 10850.0 shares on Jan 05 ’24.
